Abstract

Practice guidelines from the American Academy of Neurology for the determination of brain death in adults define brain death as “the irreversible loss of function of the brain, including the brainstem.” Neurological determination of brain death is primarily based on clinical examination; if clinical criteria are met, a definitive confirmatory test is indicated. The apnea test remains the gold standard for confirmation. In patients with factors that confound the clinical determination or when apnea tests cannot safely be performed, an ancillary test is required to confirm brain death. Confirmatory ancillary tests for brain death include (a) tests of electrical activity (electroencephalography (EEG) and somatosensory evoked potentials) and (b) radiologic examinations of blood flow (contrast angiography, transcranial Doppler ultrasound (TCD), and radionuclide methods). Of these, however, radionuclide studies are used most commonly. Here we present data from two patients with a false positive Radionuclide Cerebral Perfusion Scan (RCPS).

Highlights

  • The President’s Commission report on “guidelines for the determination of death” culminated in proposing a legal definition that led to the Uniform Determination of Death Act (UDDA)

  • The presence of blood flow in radionuclide angiography in patients with clinical brain death (BD) has been previously explained in detail [10]

  • Spieth et al reported the importance of lateral projection in reporting BD because lateral views view cerebellar blood flow in patients without clinical evidence of BD can be explained only when anterior views are used [11]. Another cause of the lack of blood flow is the use of central nervous system (CNS) depressants that mask the clinical exam; blood flow studies are rarely performed in these situations

Read more

Summary

Introduction

The President’s Commission report on “guidelines for the determination of death” culminated in proposing a legal definition that led to the Uniform Determination of Death Act (UDDA). Most state laws regarding brain death (BD) determination have their origin in the UDDA. In patients with clinical BD, a definitive test is mandated for confirmation. Apnea tests remain the gold standard for such determinations. (a) uncertainty regarding the neurological exam (e.g., patients with unknown/unclear reason for brain death),. Confirmatory tests for BD include electrical activity tests (EEG and somatosensory evoked potentials) and radiologic blood flow examinations (contrast angiography, transcranial Doppler ultrasound (TCD), and radionuclide methods). Tests demonstrating the absence of cerebral blood flow remain commonly used. We report on two patients with false positive RCPS studies. This study was approved by the Institutional Review Board of Bronx Lebanon Hospital center

Case Presentation
Discussion
Findings
Conclusion
Conflict of Interests
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call